Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female 18 years of age or older.~* Need for an operative restorative dental procedure requiring local anesthesia for a single vital maxillary tooth (other than a maxillary first, second, or third molar) with no evidence of pulpal pathology.~* Normal lip, nose, eyelid, and cheek sensation.~* Able to understand and sign the study informed consent document, communicate with the investigators, and understand and comply with the requirements of the protocol.~* Patency of the naris ipsilateral to the tooth undergoing the Study Dental Procedure.~* Resting heart rate (HR) between 55 and 100 beats per minute (bpm), inclusive.~* Seated systolic blood pressure (SBP) between 95 and 140 mm Hg, inclusive and seated diastolic blood pressure (DBP) between 60 and 90 mm Hg, inclusive.~Exclusion Criteria:~* Inadequately controlled hypertension (blood pressure greater than 140/90 mm Hg).~* Inadequately controlled active thyroid disease of any type.~* Frequent nose bleeds (≥ 5 per month).~* Having received dental care requiring a local anesthetic within the last 24 hours.~* History of allergy to or intolerance of tetracaine, benzyl alcohol, other ester local anesthetics, or para-aminobenzoic acid (as found in PABA-containing sunscreen).~* History of allergy or hypersensitivity to articaine, oxymetazoline, epinephrine, or sulfite preservatives.~* Use of a monoamine oxidase inhibitor within the 3 weeks preceding study entry.~* Nursing, pregnant, suspected of being pregnant, or trying to become pregnant. (Females of child-bearing potential will be required to take a urine pregnancy test on the day of, but prior to, study drug administration to rule out pregnancy.)~* Having received any investigational drug and/or participation in any clinical trial within 30 days prior to study participation.~* Having used oxymetazoline or phenylephrine nasal spray, nasal irrigation, or other nasal or oral decongestant on the day of the study procedure.~* History of congenital or idiopathic methemoglobinemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Kovacaine Mist, 3 sprays unilateral (Type: EXPERIMENTAL): Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
- Tetracaine Only, 3 sprays unilateral (Type: EXPERIMENTAL): Tetracaine HCl 3%
- Placebo, 3 sprays unilateral (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).